Latanoprost

    October 2015 in “ Reactions Weekly
    Image of study
    TLDR A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.
    A 61-year-old woman developed erosive pustular dermatosis of the scalp (EPDS) after using latanoprost, which she was taking for mild frontotemporal androgenetic alopecia. Following the application of a 0.1% ternary solution of latanoprost, she experienced eroded, pustular, and crusted lesions on her scalp. Physical and histologic examinations confirmed the diagnosis of EPDS, characterized by pustules, erosions, scales, and a loss of normal collagen architecture around hair follicles. Upon discontinuing latanoprost and starting treatment with methylprednisolone, zinc sulphate, and clobetasol propionate, her symptoms resolved after 6 weeks, although she had residual scarring alopecia. She remained symptom-free at the 30-week follow-up.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 134 results

      community DLQ01: A Better "Minoxidil" PGF2a synthetic analogue.

      in Research/Science  3 upvotes 1 month ago
      DLQ01, a prostaglandin F2α analog, shows promise for hair growth by directly stimulating PGE2/PGF receptors without needing conversion, and can be combined with minoxidil and retinoids like tretinoin for enhanced effectiveness. Minoxidil's efficacy may be reduced by COX-1 inhibitors, but using prostaglandin analogs like Latanoprost or Bimatoprost can help maintain its effectiveness.

      community Painkillers May Block Minoxidil

      in Research/Science  13 upvotes 1 week ago
      Painkillers like Aspirin may reduce Minoxidil's effectiveness by inhibiting the enzyme PGHS-1, which is crucial for hair growth. Using NSAIDs that inhibit COX-2 or combining Minoxidil with PGF2/E2 analogues or retinoids may enhance its efficacy.

    Similar Research

    5 / 393 results